Trial intelligence / Profile preview

Seroquel vs Risperidone in First Episode Schizophrenia

NCT00254241Phase 4Completed

Sponsor
AstraZeneca
Start
May 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of quetiapine in schizophrenia, sponsored by AstraZeneca. Started May 2002; status: completed.

02

Drugs

quetiapine
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00254241.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00254241.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call